AVITA Medical (AVHHL) Liabilities and Shareholders Equity (2020 - 2026)

AVITA Medical (AVHHL) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $47.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 17.82% year-over-year to $47.8 million; the trailing twelve-month figure through Jun 2026 stood at $226.0 million (down 21.64% YoY), and the FY2025 full-year result was $56.4 million, down 29.25% from the prior year.
• Liabilities and Shareholders Equity retreated to $47.8 million in Q2 2026 per AVHHL's latest filing, from $56.4 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $111.6 million in Q4 2023 and bottomed at $47.8 million in Q2 2026.
• Historically, Liabilities and Shareholders Equity has averaged $83.6 million across 5 years, with a median of $86.3 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity rose 13.61% in 2023, then plunged 33.81% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $98.3 million in 2022, then advanced by 13.61% to $111.6 million in 2023, then decreased by 28.6% to $79.7 million in 2024, then decreased by 29.25% to $56.4 million in 2025, then dropped by 15.28% to $47.8 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $47.8 million, $56.4 million, and $63.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.